Literature DB >> 29756641

Full sequencing and haplotype analysis of MAPT in Parkinson's disease and rapid eye movement sleep behavior disorder.

Jiao Li1,2, Jennifer A Ruskey2,3, Isabelle Arnulf4, Yves Dauvilliers5, Michele T M Hu6,7, Birgit Högl8, Claire S Leblond2,9, Sirui Zhou2,3, Amirthagowri Ambalavanan2,3, Jay P Ross2,9, Cynthia V Bourassa2,3, Dan Spiegelman2,3, Sandra B Laurent2,3, Ambra Stefani8, Christelle Charley Monaca10, Valérie Cochen De Cock11,12, Michel Boivin13,14, Luigi Ferini-Strambi15, Giuseppe Plazzi16,17, Elena Antelmi16,17, Peter Young18, Anna Heidbreder18, Catherine Labbe19, Tanis J Ferman19, Patrick A Dion2,3, Dongsheng Fan1, Alex Desautels20,21, Jean-François Gagnon20,22, Nicolas Dupré23,24, Edward A Fon2,3, Jacques Y Montplaisir20,25, Bradley F Boeve26, Ronald B Postuma2,3,27, Guy A Rouleau2,3,9, Owen A Ross28,29, Ziv Gan-Or2,3,9.   

Abstract

BACKGROUND: MAPT haplotypes are associated with PD, but their association with rapid eye movement sleep behavior disorder is unclear.
OBJECTIVE: To study the role of MAPT variants in rapid eye movement sleep behavior disorder.
METHODS: Two cohorts were included: (A) PD (n = 600), rapid eye movement sleep behavior disorder (n = 613) patients, and controls (n = 981); (B) dementia with Lewy bodies patients with rapid eye movement sleep behavior disorder (n = 271) and controls (n = 950). MAPT-associated variants and the entire coding sequence of MAPT were analyzed. Age-, sex-, and ethnicity-adjusted analyses were performed to examine the association between MAPT, PD, and rapid eye movement sleep behavior disorder.
RESULTS: MAPT-H2 variants were associated with PD (odds ratios: 0.62-0.65; P = 0.010-0.019), but not with rapid eye movement sleep behavior disorder. In PD, the H1 haplotype odds ratio was 1.60 (95% confidence interval: 1.12-2.28; P = 0.009), and the H2 odds ratio was 0.68 (95% confidence interval: 0.48-0.96; P = 0.03). The H2/H1 haplotypes were not associated with rapid eye movement sleep behavior disorder.
CONCLUSIONS: Our results confirm the protective effect of the MAPT-H2 haplotype in PD, and define its components. Furthermore, our results suggest that MAPT does not play a major role in rapid eye movement sleep behavior disorder, emphasizing different genetic background than in PD in this locus.
© 2018 International Parkinson and Movement Disorder Society. © 2018 International Parkinson and Movement Disorder Society.

Entities:  

Keywords:  MAPT; Parkinson's disease; REM sleep behavior disorder; genetics

Mesh:

Substances:

Year:  2018        PMID: 29756641     DOI: 10.1002/mds.27385

Source DB:  PubMed          Journal:  Mov Disord        ISSN: 0885-3185            Impact factor:   10.338


  14 in total

1.  Association of MAPT H1 subhaplotypes with neuropathology of lewy body disease.

Authors:  Michael G Heckman; Koji Kasanuki; Rebecca R Brennan; Catherine Labbé; Emily R Vargas; Alexandra I Soto; Melissa E Murray; Shunsuke Koga; Dennis W Dickson; Owen A Ross
Journal:  Mov Disord       Date:  2019-06-24       Impact factor: 10.338

2.  Development and Validation of a Predictive Nomogram for Possible REM Sleep Behavior Disorders.

Authors:  Hong Lai; Xu-Ying Li; Junya Hu; Wei Li; Fanxi Xu; Junge Zhu; Raoli He; Huidan Weng; Lina Chen; Jiao Yu; Xian Li; Yang Song; Xianling Wang; Zhanjun Wang; Wei Li; Rong Kang; Yuling Li; Junjie Xu; Yuanfei Deng; Qinyong Ye; Chaodong Wang
Journal:  Front Neurol       Date:  2022-06-29       Impact factor: 4.086

Review 3.  Tau and MAPT genetics in tauopathies and synucleinopathies.

Authors:  Etienne Leveille; Owen A Ross; Ziv Gan-Or
Journal:  Parkinsonism Relat Disord       Date:  2021-09-14       Impact factor: 4.402

4.  Targeted sequencing of Parkinson's disease loci genes highlights SYT11, FGF20 and other associations.

Authors:  Uladzislau Rudakou; Eric Yu; Lynne Krohn; Jennifer A Ruskey; Farnaz Asayesh; Yves Dauvilliers; Dan Spiegelman; Lior Greenbaum; Stanley Fahn; Cheryl H Waters; Nicolas Dupré; Guy A Rouleau; Sharon Hassin-Baer; Edward A Fon; Roy N Alcalay; Ziv Gan-Or
Journal:  Brain       Date:  2021-03-03       Impact factor: 13.501

5.  A Specific Diplotype H1j/H2 of the MAPT Gene Could Be Responsible for Parkinson's Disease with Dementia.

Authors:  Imane Smaili; Imane Hajjaj; Rachid Razine; Houyam Tibar; Ayyoub Salmi; Naima Bouslam; Ahmed Moussa; Wafa Regragui; Ahmed Bouhouche
Journal:  Case Rep Genet       Date:  2020-12-03

Review 6.  Biomarkers of conversion to α-synucleinopathy in isolated rapid-eye-movement sleep behaviour disorder.

Authors:  Mitchell G Miglis; Charles H Adler; Elena Antelmi; Dario Arnaldi; Luca Baldelli; Bradley F Boeve; Matteo Cesari; Irene Dall'Antonia; Nico J Diederich; Kathrin Doppler; Petr Dušek; Raffaele Ferri; Jean-François Gagnon; Ziv Gan-Or; Wiebke Hermann; Birgit Högl; Michele T Hu; Alex Iranzo; Annette Janzen; Anastasia Kuzkina; Jee-Young Lee; Klaus L Leenders; Simon J G Lewis; Claudio Liguori; Jun Liu; Christine Lo; Kaylena A Ehgoetz Martens; Jiri Nepozitek; Giuseppe Plazzi; Federica Provini; Monica Puligheddu; Michal Rolinski; Jan Rusz; Ambra Stefani; Rebekah L S Summers; Dallah Yoo; Jennifer Zitser; Wolfgang H Oertel
Journal:  Lancet Neurol       Date:  2021-08       Impact factor: 44.182

7.  Reference SVA insertion polymorphisms are associated with Parkinson's Disease progression and differential gene expression.

Authors:  Abigail L Pfaff; Vivien J Bubb; John P Quinn; Sulev Koks
Journal:  NPJ Parkinsons Dis       Date:  2021-05-25

8.  Fine-Mapping of SNCA in Rapid Eye Movement Sleep Behavior Disorder and Overt Synucleinopathies.

Authors:  Lynne Krohn; Richard Y J Wu; Karl Heilbron; Jennifer A Ruskey; Sandra B Laurent; Cornelis Blauwendraat; Armaghan Alam; Isabelle Arnulf; Michele T M Hu; Yves Dauvilliers; Birgit Högl; Mathias Toft; Kari Anne Bjørnarå; Ambra Stefani; Evi Holzknecht; Christelle Charley Monaca; Beatriz Abril; Giuseppe Plazzi; Elena Antelmi; Luigi Ferini-Strambi; Peter Young; Anna Heidbreder; Valérie Cochen De Cock; Brit Mollenhauer; Friederike Sixel-Döring; Claudia Trenkwalder; Karel Sonka; David Kemlink; Michela Figorilli; Monica Puligheddu; Femke Dijkstra; Mineke Viaene; Wolfang Oertel; Marco Toffoli; Gian Luigi Gigli; Mariarosaria Valente; Jean-François Gagnon; Mike A Nalls; Andrew B Singleton; Alex Desautels; Jacques Y Montplaisir; Paul Cannon; Owen A Ross; Bradley F Boeve; Nicolas Dupré; Edward A Fon; Ronald B Postuma; Lasse Pihlstrøm; Guy A Rouleau; Ziv Gan-Or
Journal:  Ann Neurol       Date:  2020-02-12       Impact factor: 11.274

9.  Role of Alterations in Protein Kinase p38γ in the Pathogenesis of the Synaptic Pathology in Dementia With Lewy Bodies and α-Synuclein Transgenic Models.

Authors:  Michiyo Iba; Changyoun Kim; Jazmin Florio; Michael Mante; Anthony Adame; Edward Rockenstein; Somin Kwon; Robert Rissman; Eliezer Masliah
Journal:  Front Neurosci       Date:  2020-03-31       Impact factor: 4.677

10.  The Quebec Parkinson Network: A Researcher-Patient Matching Platform and Multimodal Biorepository.

Authors:  Ziv Gan-Or; Trisha Rao; Etienne Leveille; Clotilde Degroot; Sylvain Chouinard; Francesca Cicchetti; Alain Dagher; Samir Das; Alex Desautels; Janelle Drouin-Ouellet; Thomas Durcan; Jean-François Gagnon; Angela Genge; Jason Karamchandani; Anne-Louise Lafontaine; Sonia Lai Wing Sun; Mélanie Langlois; Martin Levesque; Calvin Melmed; Michel Panisset; Martin Parent; Jean-Baptiste Poline; Ronald B Postuma; Emmanuelle Pourcher; Guy A Rouleau; Madeleine Sharp; Oury Monchi; Nicolas Dupré; Edward A Fon
Journal:  J Parkinsons Dis       Date:  2020       Impact factor: 5.568

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.